{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:51:05Z","timestamp":1770475865892,"version":"3.49.0"},"reference-count":62,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1517\/17425255.4.5.629","type":"journal-article","created":{"date-parts":[[2008,5,19]],"date-time":"2008-05-19T01:17:32Z","timestamp":1211159852000},"page":"629-638","source":"Crossref","is-referenced-by-count":20,"title":["Sertindole: pharmacological and clinical profile and role in the treatment of schizophrenia"],"prefix":"10.1517","volume":"4","author":[{"given":"Edoardo","family":"Spina","sequence":"first","affiliation":[{"name":"University of Messina, Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, Policlinico Universitario, Via Consolare Valeria, 98125 Messina, Italy ; ;"},{"name":"University of Messina, IRCCS Centro Neurolesi \u2018Bonino-Pulejo\u2019, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Zoccali","sequence":"additional","affiliation":[{"name":"University of Messina, Department of Neurosciences, Psychiatric and Anesthesiological Sciences, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2008,5,18]]},"reference":[{"key":"e_1_3_1_3_1","unstructured":"Stahl S. Essential psychopharmacology of antipsychotics and mood stabilizers. Cambridge: CUP; 2002"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721110-00004"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.10.1079"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620030-00005"},{"key":"e_1_3_1_8_1","first-page":"1825","volume":"7","author":"Lindstrom","year":"2006","unstructured":"Lindstrom E, Levander S. Sertindole: efficacy and safety in schizophrenia. Exp Opin Drug Saf 2006;7:1825-34","journal-title":"Exp Opin Drug Saf"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651500210340"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.430220306"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01245352"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(97)00112-7"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620050-00004"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(24)38891-3","volume":"295","author":"Herrick-Davis","year":"2000","unstructured":"Herrick-Davis K, Grinde E, Teitler M. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. J Pharmacol Exp Ther 2000;295:226-32","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100814"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1083-5"},{"key":"e_1_3_1_17_1","first-page":"25","volume":"40","author":"Petit-Tabou\u00e9","year":"1999","unstructured":"Petit-Tabou\u00e9 MC, Landeau B, Barr\u00e9 L, et al. Parametric PET imaging of 5HT2A receptor distribution with 18F-setoperone in the normal human cortex. J Nucl Med 1999;40:25-32","journal-title":"J Nucl Med"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00242-D"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245612"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.05.021"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0774-3"},{"key":"e_1_3_1_22_1","author":"Rodefer","year":"2007","unstructured":"Rodefer JS, Nguyen TN, Karlsson JJ, Arnt J. Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6; receptor antagonist: comparison among antipsychotics. Neuropsychopharmacology 2007 [Epub ahead of print]","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528010-00003"},{"key":"e_1_3_1_24_1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3565(24)37654-2","volume":"286","author":"Rampe","year":"1998","unstructured":"Rampe D, Murawsky MK, Grau J, et al. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. J Pharmacol Exp Ther 1998;286:788-93","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)02074-5"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262110-00006"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00011"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.1.64"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.052753"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651500215969"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145705005250"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-081X(199708)18:6<533::AID-BDD42>3.0.CO;2-J"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90063-1"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050278"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/js970446m"},{"key":"e_1_3_1_36_1","unstructured":"H. Lundbeck A\/S. Serdolect (sertindole) monograph. Copenhagen: H Lundbeck A\/S; 2005"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.001230"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0437-9"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746050-00001"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2007.00017.x"},{"key":"e_1_3_1_41_1","first-page":"12","volume":"57","author":"Ereshefsky","year":"1996","unstructured":"Ereshefsky L. Pharmacokinetics and drug interactions: update for new antipsychtics. J Clin Psychiatry 1996;57(Suppl 11):12-25","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050505"},{"key":"e_1_3_1_43_1","first-page":"146","volume":"36","author":"Wong","year":"1998","unstructured":"Wong SL, Cao G, Mack R, Granneman GR. Lack of CYP3A inhibition effects of sertindole on terfenadine in healthy volunteers. Int J Clin Pharmacol Ther 1998;36:146-51","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04287.x"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245618"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.6.782"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651500050518406"},{"key":"e_1_3_1_48_1","first-page":"61","volume":"34","author":"Daniel","year":"1998","unstructured":"Daniel DG, Wozniak P, Mack RJ, et al. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. Psychopharmacol Bull 1998;34:61-9","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000177020.26311.a7"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199702001-00005"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418002-00003"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-990291"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651500052048758"},{"key":"e_1_3_1_54_1","first-page":"CD001715","volume":"3","author":"Lewis","year":"2005","unstructured":"Lewis R, Bagnall AM, Leitner M. Sertindole for schizophrenia. Cochrane Database Syst Rev 2005;3:CD001715","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200511000-00010"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.11.1686"},{"key":"e_1_3_1_57_1","first-page":"S422","volume":"7","author":"Kasper","year":"2004","unstructured":"Kasper S, Tuomi M. The clinical safety and tolerability profile of sertindole [abstract no. S422]. Int J Neuropsychopharmacol 2004;7(Suppl 1):S422","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_3_1_58_1","first-page":"S207","volume":"7","author":"Mack","year":"1997","unstructured":"Mack R, Driscoll R, Silber C. The long term cardiovascular safety of sertindole. Eur Neuropsychopharmacol 1997;7(Suppl 2):S207","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200102000-00003"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000104913.75206.62"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988110101500212"},{"key":"e_1_3_1_62_1","first-page":"S116","volume":"11","author":"Branford","year":"2002","unstructured":"Branford D, Thompson B, Mouldon C. Mortality in three comparative cohorts of patients who received sertindole, risperidone and olanzapine: a hospital-based, retrospective study [abstract no. 247]. Pharmacoepidemiol Drug Saf 2002;11(Suppl 1):S116","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1425"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.848"}],"container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/17425255.4.5.629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:59:38Z","timestamp":1770407978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17425255.4.5.629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1517\/17425255.4.5.629"],"URL":"https:\/\/doi.org\/10.1517\/17425255.4.5.629","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}